ArticleEvidence-based complementary and alternative medicine : eCAM2021

Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials.

Yu-Xin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.